Vijaya Diagnostic Centre Limited (VIJAYA.NS)
Vijaya Diagnostic Centre Limited operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Hyderabad, TS, IN. The stock last traded at $1474.10, down 0.83% on the session, giving a market capitalisation of $151.68B. Its beta of 0.34 implies it has historically moved less than the broad market.
Vijaya Diagnostic Centre Limited delivers a broad spectrum of diagnostic services to patients across India. Its extensive laboratory offerings include clinical biochemistry, haematology (and immune-haematology), clinical pathology, histopathology, cytopathology, microbiology, serology, cytogenetics, and molecular pathology. For imaging, the company provides advanced radiology services such as magnetic resonance imaging (MRI), multi-slice CT, 3D dental CBCT, mammography, DEXA/bone densitometry, ultrasound with color doppler, nuclear medicine including PET/CT, and digital X-rays. Beyond these, specialized services cover cardiology, neurology, and gastroenterology. The center also offers health check-up packages and convenient home sample collection. Headquartered in Hyderabad, India, and founded in 1981, Vijaya Diagnostic Centre operates a significant network of 80 diagnostic centers and 11 reference laboratories. These facilities are spread across 13 cities and towns, primarily in Telangana and Andhra Pradesh, alongside the National Capital Region and Kolkata.
Vijaya Diagnostic Centre Limited is most often compared with the following Healthcare names: